BDPI

Overview

BDPI is the a BODIPY derivative. BDPI reveals a high O 2 quantum yield and exhibits phototoxicity that inhibits HeLa with an IC 50 of 0.6 µg/mL. BDPI nanoarticles can be taken up by HeLa, producing fluorescence signals in the cells, and can be used as cell imaging agent. BDPI nanoarticles exhibit antitumor efficacy in mouse models.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > Fluorescent Dye

Product Information

• Catalog No.: HY-W112239
• CAS No.: 1083009-44-2
• Molecular Formula: C19H17BF2I2N2
• Molecular Weight: 575.97
• Purity: 99.98%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source